Categories: STAT

2/8/2017

STAT said drug ‘halved’ prostate cancer deaths, but that’s not the full picture

1/3/2017

By including independent viewpoints, STAT takes a more measured approach to coverage of brain cancer immunotherapy

12/12/2016

Solid but single-sourced: STAT’s coverage of Alzheimer’s drugs needed an independent voice

12/2/2016

STAT’s roundup of allergy treatment research needed discussion of costs

10/14/2016

PARP inhibitors: STAT’s look at new ovarian cancer drugs should have established why we need more on the market

9/29/2016

STAT’s look at migraine drugs in development skimmed over key research details

8/29/2016

Powerful patient video anecdote in STAT’s story overshadows realities of new treatment for essential tremor

7/13/2016

STAT’s story on postpartum depression drug– ‘a paradigm shift’ that needed more scrutiny

2 6/9/2016

Well done: STAT story on extended use of aromatase inhibitors for breast cancer

4/13/2016

An array of sources make this STAT story on aspirin task force recommendations very strong